PIŚMIENNICTWO

  1. Grzyb K., Meresinska M., Religioni U., Juszczyk G., Płaczek J., Neumann-Podczaska A., Szymanski FM., Chełstowska B., Wieczorowska-Tobis K., Cofta Sz., Tobis S., Staszewski R., Vaillancourt R., Majewski R., Hernik J., Fehir Sola K., Blicharska E., Kazmierczak J., Rutkowska E., Prygiel E., Skierska M., Nawara M., Korbiewska I., Krysínski I., Merks P. Implementation of the Patient Counselling Service at the Cancer Hospital in Radom, Poland. Int. J. Environ. Res. Public Health 2022, 19, 1364     https://mdpi-res.com/d_attachment/ijerph/ijerph-19-13642/article_deploy/ijerph-19-13642.pdf?version=1666330708&fbclid=IwAR2G3l5WTj1JH1lnQ5gXtwKvKFsvBX_QsBrsG_KsG6DmHFznvAusIrBNyRw
  2. Pazan F., Petrovic M., Cherubini A., Cruz‑Jentoft AJ., Denkinger M., van der Cammen TJM., Stevenson JM., Ibrahim K., Rajkumar C., Stordal Bakken M., Crome P., Guðmundsson A., Knol W., Snijders BMG., O’Mahony D., Serra‑Rexach JA., Soulis G., van Marum RJ., Ziere G., Mair A., Burkhardt H., Neumann‑Podczaska A., Wieczorowska‑Tobis K., Fernandes MA., Gruner H., van der Velde N., Wehling M. A Systematic Review of the Current Evidence from Randomised Controlled Trials on the Impact of Medication Optimisation or Pharmacological Interventions on Quantitative Measures of Cognitive Function in Geriatric Patients.
    https://link.springer.com/content/pdf/10.1007/s40266-022-00980-9.pdf
  3. Merks P. Zakres i jakość usług farmaceutycznych w opinii pacjentów w Polsce i Wielkiej Brytanii. Rozprawa doktorska. Katedra Technologii Postaci Leku Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Uniwersytet Mikołaja Kopernika w Toruniu, Bydgoszcz 2017.
  4. Merks P, Olszewska A, Dehili C i wsp.. Consultation room as one of the important aspects of implementation of advanced pharmaceutical services in Poland. Farm Pol. 2013; 69(7): 399–407.
  5. Akici A, Kalaca S, Ugurlu U i wsp. Patient knowledge about drugs prescribed at primary healthcare facilities. Pharmacoepidemiol Drug Saf. 2004;13:871–876.
  6. Dick EC, Jennings LC, Mink KA i wsp. Aerosol transmission of rhinovirus colds. J Infect Dis. 1987;156:442–448.
  7. Dowse R, Ehlers M. Medicine labels incorporating pictograms: do they influence understanding and adherence? Patient Educ Couns. 2005;58(1):63–70.
  8. Haynes RB. Determinants of compliance: the disease and the mechanics of treatment. Johns Hopkins University Press, Baltimore 1979.
  9. Hepler CD. The third wave in pharmaceutical education: the clinical movement. Am J Pharm Educ. 1987;51(4):369–385.
  10. Houts PS, Doak CC, Doak LG, Loscalzo MJ. The role of pictures in improving health communication: A review of research on attention, comprehension, recall, and adherence. Patient Educ Couns. 2006;61(2):173–190.
  11. National Health System, www.nhs.uk [dostęp: 22.03.2017].
  12. Jaye C, Hope J, Martin IR. What do general practice patients know about their prescription medications? New Zealand Med J. 2002;115(1162):1–10.
  13. Katz MG, Kripalani S, Weiss BD. Use of pictorial aids in medication instructions: a review of the literature. Am J Health Syst Pharm. 2006;63(23):2391–2397.
  14. MacKeighan L, Larson L. Development and validation of an instrument to measure patient satisfaction with pharmacy services. Med Care. 1989;27(5):522–536.
  15. MacKinnon NJ. Striving beyond patient satisfaction: a road map for pharmacists (Internet). www.InetCE.com, 2005.
  16. Making best use of consultation area. A guide for NPA members in England and Wales, http://hampshirelpc.org.uk/sites/default/files/user18/Making_best_use_of_consultation_areas.pdf [dostęp: 22.03.2017].
  17. Mobach MP. The counter and consultation room work explored in the Netherlands. Pharm World Sci. 2008;30:360–366.
  18. Phillips DP, Christenfeld N, Glynn LM. Increase in US medication-error deaths between 1983 and 1993. Lancet. 1998;351:643–644.
  19. Rand CS. Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol. 1993:72:68–74.
  20. Roy CJ, Milton DK. Airborne transmission of communicable infection: the exclusive pathways. N Engl J Med. 2004;350;1710–1712.
  21. Rozporządzenie Ministra Zdrowia z dnia 26 września 2002 r. w sprawie wykazu pomieszczeń wchodzących w skład powierzchni podstawowej i pomocniczej apteki. Dz. U. z 2002 r. nr 161, poz. 1338.
  22. Schommer J, Kucukarslan S. Measuring patient satisfaction with pharmaceutical services. Am J Health Syst Pharm. 1997;54(23):41–43.
  23. Sieradzki E (red.). Opieka farmaceutyczna w praktyce aptecznej. Wydawnictwo Akademii Medycznej w Warszawie, Warszawa 2004.
  24. Simpson SH, Eurich DT, Majumdar SR i wsp. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333:15.
  25. Skowron A. Model opieki farmaceutycznej dla polskiego systemu zdrowotnego, Wydawnictwo FALL, Kraków 2011.
  26. Statutory Instruments, 2005 no. 641. National Health Service, England. Regulations 2005.
  27. Streifel AJ. Design and maintenance of hospital ventilation systems and prevention of airborne nosocomial infections. W: Mayhall CG (red.). Hospital epidemiology and infection control. Wyd. 2. Lippincott Williams & Wilkins, Philadelphia 1999.
  28. Tellier R. Aerosol transmission of influenza A: a review of new studies. JR Soc Interface. 2009;6:S783–S790.
  29. Traverso M, MacKeigan L. Instruments for measuring patient satisfaction with pharmacy services in the Spanish language. Pharm World Sci. 2005;27(4):281–284.
  30. Tully MP, Hassell K, Noyce P. Advice – giving in community pharmacies in the UK. J Health Serv Res Policy. 1997;2:38–50.
  31. WHO. Adherence to long-term therapies: evidence for action, http://www.who.int/chp/knowledge/publications/adherence_report/en/index.html [dostęp: 22.03.2017].
  32. Abood RR, Brushwood DB. Pharmacy practice and the law. Aspen Publishers Inc, Gaithersburg 1994.
  33. Akici A, Kalaca S, Ugurlu U i wsp. Patient knowledge about drugs prescribed at primary healthcare facilities. Pharmacoepidemiol Drug Saf. 2004;13:871–876.
  34. Brody JE. Americans gamble on herbs as medicine. The New York Times February 9, 1999.
  35. Dowse R, Ehlers M. Medicine labels incorporating pictograms: do they influence understanding and adherence? Patient Educ Counsel. 2005;58(1):63–70.
  36. Foster S, Tyler VE (red.). Tyler’s honest herbals. The Haworth Herbal Press, New York 1999.
  37. Haynes RB. Determinants of compliance: the disease and the mechanics of treatment. Johns Hopkins University Press, Baltimore 1979.
  38. Houts PS, Doak CC, Doak LG, Loscalzo MJ. The role of pictures in improving health communication: A review of research on attention, comprehension, recall, and adherence. Patient Educ Couns. 2006;61(2):173–190.
  39. Jaye C, Hope J, Martin IR. What do general practice patients know about their prescription medications? New Zealand Med J. 2002;115(1162):1–10.
  40. Jaye C, Hope J, Martin IR. What do general practice patients know about their prescription medications? New Zealand Med J. 2002;115(1162):1–10.
  41. Jeetu G, Girish T. Prescription drug labeling medication errors: a big deal for pharmacists. J Young Pharm. 2010;2(1):107–111.
  42. Kasture PV, Mohite MT i wsp.. Pharmaceutical labeling; a review. Pharm Rev. 2008.
  43. Katz MG, Kripalani S, Weiss BD. Use of pictorial aids in medication instructions: a review of the literature. Am J Health Sys Pharm. 2006;63(23):2391–2397.
  44. Koffuor GA, Anto BP, Abaitey AK. Error-provoking conditions in the medication use process: the case of a government hospital in Ghana. J Patient Saf. 2012;8(1):22–25.
  45. Krueger KP, Berger BA, Felkey B. Medication adherence and persistence: a comprehensive review. Adv Ther. 2005;22(4):313–356.
  46. Ludescher NO, Vergilio RR, Lucio CC, Santos JEG. Interface of drug use. Work. 2012;41:5631–5633.
  47. Morrell RW, Park DC, Poon LW. Quality of instructions on prescription drug labels: Effects on memory and comprehension in young and old adults. Gerontologist. 1989; 29(3):345–354.
  48. O’Brien MK, Petrie K, Raeburn J. Adherence to medication regimens: updating a complex medical issue. Med Care Rev. 1992;49(4):435–454.
  49. Phillips DP, Christenfeld N, Glynn LM. Increase in US medication-error deaths between 1983 and 1993. Lancet. 1998;351:643–644.
  50. Rand CS. Measuring adherence with therapy for chronic diseases: Implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol. 1993;72:68D–74D.
  51. Rand CS. Measuring adherence with therapy for chronic diseases: Implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol. 1993;72:68D–74D.
  52. Simpson SH, Eurich DT, Majumdar SR i wsp. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15.
  53. Teagarden JR, Nagle B, Aubert RE i wsp.. Dispensing error rate in a highly automated mail-service pharmacy practice. Pharmacotherapy. 2005;25(11):1629–1635.
  54. Wallace LS, Keenum AJ, DeVoe JE. Characteristics of container labeling in a sample of commonly prescribed children’s oral medications. Res Social Adm Pharm. 2010;6(4):272–279.
  55. WHO. Adherence to long-term therapies: Evidence for action, http://www.who.int/chp/knowledge/publications/adherence_report/en/index.html [dostęp: 19.02.2012].